Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
Friday, March 03, 2023Aptorum Group Limited a clinicalstage biopharmaceutical company announces the completion of an end of Phase EOP meeting with the US Food and Drug Administration US FDA SACT is a repurposed small molecule drug formulated in oral suspension targeting...
ProBioGen’s Growth Strategy Continues Successfully
Thursday, March 02, 2023ProBioGen has seen significant growth with over employees now working across its three locations in Berlin In line with this growth three crucial positions have been filled Julian Collins has been appointed as Senior Vice President Head of People O...
AIT Worldwide Logistics Expands Global Network, Pharmaceutical Logistics Expertise to South Korea
Thursday, March 02, 2023Global freight forwarder AIT Worldwide Logistics is proud to announce its debut facility in the worlds th largest economy with the opening of the companys Seoul location the first of several planned AIT offices in South Korea According to AITs Senior...
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Thursday, March 02, 2023Pharmapack Europe February closed earlier this month with the drug delivery and packaging community predicting sizeable growth through and sustainability dominating the at show agenda and innovations The event widely seen as a key bellwether for...
Avadel Pharmaceuticals Requests Final FDA Approval for LUMRYZ™ (sodium oxybate) extended-release oral suspension
Thursday, March 02, 2023Avadel Pharmaceuticals plc a biopharmaceutical company focused on transforming medicines to transform lives announced today that it has submitted an amendment to the US Food and Drug Administration FDA requesting final approval for LUMRYZ for the tre...
Lantern Pharma Expands Clinical Leadership Team to Further Advance its Ongoing and Upcoming Clinical Trials
Thursday, March 02, 2023Lantern Pharma Inc a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence AI and machine learning ML platform to transform the cost pace and timeline of oncology drug discovery and development today announced th...
Paragon Genomics Partners with Devyser to Expand CleanPlex® Technology Distribution in Italy
Wednesday, March 01, 2023Paragon Genomics a Californiabased leader in advanced ampliconbased target enrichment solutions for nextgeneration sequencing NGS and precision medicine today announced a partnership with Devyser a world leader in diagnostic kits and solutions for ad...
AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology Procedures
Wednesday, March 01, 2023AcelRx Pharmaceuticals Inc a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings today announced the publication of a report arising from a series of rhino...
SerYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV)
Tuesday, February 28, 2023SerYmun Yeast GmbH serYmun an animal health vaccine development company based in Germany announces the breakthrough in the development of their first pig vaccine candidate against porcine parvovirus A controlled target animal study proved the protect...
KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Monday, February 27, 2023KalVista Pharmaceuticals Inc a clinical stage pharmaceutical company focused on the discovery development and commercialization of oral small molecule protease inhibitors today presented five posters at the American Academy of Allergy Asthma Immunol...
